Open-label RCT in 210 people with TB infection in Sydney: 3 months of weekly isoniazid plus rifapentine (with SMS reminders) gave higher completion than 4 months of daily rifampicin (84.9% vs 65.4%; RR 1.30); adverse events 24.5% vs 20.2%.
RCTn = 210
Chang et al. Three Months of Weekly Rifapentine and Isoniazid Versus Four Months of Daily Rifampicin for Tuberculosis Infection: A Randomized Controlled Trial